Companies

Abridge

abridge.com

Abridge uses generative AI to turn clinical conversations into evidence-linked documentation for healthcare organizations.

HQPittsburgh, Pennsylvania, United States
Employees201-1000
Funding$778M
Valuation$5.3B
Revenue$117M ARR
40 active roles
Profile 6mo agoJobs checked 17h ago
Healthcare AIAI ApplicationB2B SaaSSeries E+$200M-$1B

About

Abridge builds an enterprise AI platform that captures patient-clinician conversations and converts them into structured, billable clinical documentation. It sells primarily to healthcare systems and differentiates through real-time EHR integrations, auditable AI, and Linked Evidence that maps generated summaries to source conversation evidence.

Market

Abridge competes in the healthcare ambient AI and clinical documentation market, converting patient-clinician conversations into structured, EMR-integrated clinical notes. It positions itself as an enterprise-grade, AI-native platform for health systems, differentiating through healthcare-specific ASR and purpose-built LLMs, multilingual performance, Linked Evidence that connects summaries to source transcript/audio, and deep clinical and EMR integration.

Target Customers

Abridge primarily targets large healthcare enterprises and health systems seeking enterprise-grade clinical documentation and ambient AI, including organizations with complex EMR environments and large clinician populations. Key users and buyers are clinicians, health-system clinical leadership, and enterprise healthcare IT/operations teams; the platform also supports patients through more understandable visit documentation and follow-up insights.

At a Glance

Problem

Abridge addresses the administrative burden of clinical documentation: clinicians spend substantial time converting patient encounters into notes, while traditional documentation solutions can be too expensive or slow for modern health systems. Patients face a parallel problem because conventional records often fail to clearly capture the key details of a care plan. The central economic opportunity is to return clinician time to patient care, with the killer use case being automatic documentation of the encounter immediately after—or during—the visit.

Product / Service

Abridge is an enterprise AI platform for clinical conversations. Its software uses ambient listening to capture the patient-clinician conversation, creates a transcript, identifies speakers and language, structures the discussion around clinically relevant information, and generates contextually aware, clinically useful, and billable notes. Additional models verify the accuracy of the note and support efficient editing, while the platform can integrate into existing workflows and electronic health records.

The delivery model is designed for health systems rather than only individual clinicians: Abridge Enterprise provides centralized tools for security, compliance, and deployment across clinicians. The resulting notes can reduce documentation time, support actionable care plans and reminders for patients, and enable clinicians to spend more time on care instead of administrative work.

Market

Abridge competes in the enterprise healthcare AI, ambient clinical intelligence, and AI medical-scribe market. The category includes products that listen to clinical encounters and turn them into structured documentation; Ambience Healthcare is a named competitor in the available research. Abridge is also extending beyond point documentation toward a broader AI clinical assistant and clinician-intelligence platform serving patients, providers, payers, and health systems.

The evidence indicates meaningful commercial and market traction rather than a pre-revenue concept: Abridge announced an enterprise agreement giving thousands of clinicians at Yale New Haven Health access to the product, partnered with Google Cloud, and was recognized as a 2025 and 2026 Best in KLAS market leader in ambient AI. It also announced a $150 million financing round. The available evidence does not provide revenue or ARR figures, so the company's precise financial scale cannot be determined.

Founders & Leadership

Shiv RaoFounder
CEO, Co-Founder
Zachary LiptonFounder
Chief Technologist and Scientific Officer, Co-Founder
Florian MetzeFounder
Co-Founder
Sandeep KonamFounder
Co-Founder
San OoChief Technology Officer
Brian WilsonChief Commercial Officer
Janie LeeVice President, Product

Funding History

2019-01
Seed$5M

Union Square Ventures, Pillar Ventures

2022-08
Series A-1$12.5M

Wittington Ventures

2023-10
Series B$30M

Spark Capital

2024-02
Series C$150M

Lightspeed Venture Partners, Redpoint Ventures

2025-02
Series D$250M

Elad Gil, IVP

2025-06
Series E$300M

Andreessen Horowitz (a16z)

2026-04
Series E extension$316M

Andreessen Horowitz (a16z)

Recent News

2026-07-28
Abridge buys agentic AI, workflow automation company

Abridge acquired Altrina, a company that builds AI agents to automate multi-step workflows across industries. The acquisition expands Abridge’s clinical platform toward agentic workflow automation.

2026-07-20partnership
Why CHRISTUS Health Expanded with AI Partner Abridge: Continuous Innovation

CHRISTUS Health expanded its relationship with Abridge through an unlimited enterprise agreement, extending the platform across inpatient care and launching a nursing documentation pilot.

2026-06-12partnership
Nvidia Teams Up with Abridge to Build AI Healthcare Model

NVIDIA and Abridge are collaborating on a healthcare-specific foundation model tailored to clinical conversations. The model is intended to improve accuracy, reliability, auditability, and customization across clinical workflows.

2026-06-11product
Abridge Unveils Unified Healthcare Intelligence Platform

Abridge introduced a patient-centered clinician intelligence platform connecting care delivery, payment, and evidence-based workflows. The launch included an NVIDIA collaboration on a foundation model purpose-built for clinical conversations.

2026-06-11funding
Abridge Secures Eli Lilly Investment and Expands Payer and Research Workflows

Eli Lilly made a strategic investment in Abridge to support evidence-based care and research access. Abridge also announced expanded capabilities connecting clinical conversations with payer, life-science, and clinical-trial workflows; the investment amount was not disclosed.

2026-04-15partnership
Abridge Partners with NEJM and JAMA to Bring Peer-Reviewed Research into Clinical Workflows

Abridge partnered with the New England Journal of Medicine and JAMA to bring peer-reviewed evidence into clinical workflows before, during, and after patient conversations.

2026-04-15partnership
Abridge Expands Clinical Decision Support with UpToDate and New Content Integrations

Abridge expanded its clinical decision-support capabilities through a partnership with Wolters Kluwer’s UpToDate and additional content integrations.

2026-04funding
Abridge Closes a $316M Series E Extension at a $5.3B Valuation

Abridge closed a $316 million Series E extension at a reported $5.3 billion valuation, bringing its cumulative funding to roughly $830 million according to contemporaneous coverage.

2026-02-24partnership
UCHealth Rapidly Deploys Abridge Systemwide, Enhancing Patient and Provider Experience

UCHealth expanded Abridge across care sites following a nine-month pilot involving 250 providers. The rollout supports systemwide clinical documentation and the development of new inpatient documentation workflows.

2026-01-12partnership
Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation

Abridge and Availity began developing real-time prior-authorization workflows that use shared clinical context from patient conversations to support administrative processes and improve payer-provider coordination.

Active Roles

40
NYC Office/Customer Success Manager/1d ago
California/Engineering/17d ago
California/Engineering/21d ago
SF Office/HR & Recruiting/21d ago
Senior Physician ExecutiveRemote$160k – $260k
Remote - Tier 1/Other/30d ago
SF Office/Legal/34d ago
SF Office/HR & Recruiting/42d ago
SF Office/Product/44d ago
Sales Director, PayersRemote$200k – $200k
Remote - Tier 1/Sales/44d ago
SF Office/Operations/44d ago
SF Office/Design/50d ago
SF Office/Product/73d ago
SF Office/Forward-Deployed Engineer/73d ago
Senior Event Marketer$156k – $180k
SF Office/Marketing/78d ago
SF Office/Engineering/83d ago
SF Office/Engineering/85d ago

Business Model

Abridge sells negotiated B2B enterprise subscription licenses to healthcare organizations, principally health systems, with reported pricing of approximately $2,500 per clinician annually or $199 per seat monthly. Additional commercial opportunities include extending its conversational-intelligence platform to payers and life-sciences organizations.

Products

Abridge generative-AI clinical documentation platformAmbient clinical conversation capture and summarizationContextual Reasoning EngineLinked Evidence and auditable AI verificationClinical conversation speech and language technologyAfter-visit insights and patient-centered clinician intelligence

Customers

Kaiser PermanenteMayo ClinicJohns Hopkins MedicineDuke HealthUPMCYale New Haven

Tech Stack

Generative AIPurpose-built large language models (LLMs)Healthcare automatic speech recognition (ASR)Multimodal healthcare foundation modelsLinked Evidence and auditable AIKubernetesGoogle Cloud/GKEArgo CDNVIDIA Riva

Competitors

Corti
Noteless
Heidi
HealthSage
Voicare
Freed
Augmedix
DeepScribe

Key Investors

Andreessen Horowitz, Lightspeed Venture Partners, Khosla Ventures, IVP, Redpoint Ventures, Spark Capital, CVS Health Ventures, Kaiser Permanente Ventures, Mass General Brigham Ventures